Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by csutton10on Nov 18, 2020 11:45am
173 Views
Post# 31922466

RE:RE:RE:RE:RE:RE:RE:RE:Mdx presenting at fall investor summit nov 17

RE:RE:RE:RE:RE:RE:RE:RE:Mdx presenting at fall investor summit nov 17Yes, I did got to watch/listen to the presentation. It was more or less an overview of the technology and the business model (product purchase + subscription based recurring rev.). I thought Mike did a great job considering the 30 minute time constraint for both presentation and Q/A.

The one takeaway was that Mike brought to light that MedX is close to landing a large distribution partner here in Canada...possibly a pharmacy chain. He did address the static share price and attributed it to the market waiting to see if they can acheive revenues from DermSecure, which he mentioned would be in the months leading into 2021...so Q4 of 2020?? I am sure there were some other details I am missing so if they come to mind, I will add them to this reply string.



<< Previous
Bullboard Posts
Next >>